Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-25 @ 2:09 AM
NCT ID:
NCT04363060
Eligibility Criteria:
Inclusion Criteria:
* Adult ≥ 18 ans,
* Patient with positive SARS-CoV-2 RT-PCR on nasopharyngeal sample at randomization or within the previous 48 hours,
* Patient with pneumonia diagnosed by thorax CT-scan or echography,
* Patient able to take per os medication,
* Written and signed consent of the patient,
* Patients affiliated with or benefitting from a social security scheme.
Exclusion Criteria:
* Patient hospitalized in intensive care unit,
* Patient who received more than 24 hours of antibiotic treatment for the ongoing episode,
* Chronic renal failure with a Glomerular Filtration Rate \< 20ml/min,
* Severe hepatic failure,
* Severe chronic cardiac insufficiency,
* Allergy to macrolides,
* Electrocardiogram showing corrected QT prolongation greater than 470 ms in men and 480 ms in women.
* Life-threatening presentation expected to lead to possible imminent death (based on provider assessment)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT04363060
Study Brief:
Protocol Section:
NCT04363060